Defining strategies overcoming obstacles to early diagnosis and treatment in Alzheimer’s disease: MOPEAD What is MOPEAD, who is involved and where is it taking place? Alzheimer’s disease (AD), one of the main causes of delayed AD diagnosis is the lack of awareness, in the general population, of cognitive decline. We need to clarify the meaning…
The female factor in clinical trials
The female factor in clinical trials The European Parliament will discuss a non-binding report that calls for medicine labels to state whether the drugs were specifically tested in women and whether men and women may face different side effects. The report, drafted by the Spanish MEP Beatriz Becerra Basterrechea, asks the European Commission and EU…
Next Meeting – ENVI
Meeting Committee on the Environment, Public Health and Food Safety will be in Brussels, 30-31 January 2017. They will vote inter alia on a recommendation for second reading on official controls in the food chain, a report on EU options for improving access to medicines, a motion for a resolution following an oral question on…
Smallest MRI helps tiny babies
Smallest MRI helping tiny babies One of only two purpose built neonatal MRI machines in the world is based in Sheffield where they are pioneering the use of compact MRI scanning for imaging the brains of premature babies. The machine, at the Royal Hallamshire Hospital, is one of only two purpose-built neonatal MRI scanners in…
Naps might boost mental ability in older adults
Hour long naps might boost mental ability in older adults A new study brings some good news for older adults who enjoy an afternoon nap, after finding an hour long siesta may improve memory and thinking skills. Research suggests that an afternoon nap of about 1 hour may boost the cognitive functions in older adults.…
WIRED Health 2017
WIRED Health, 30 Euston Square,London, Mar. 9th, 2017 Healthcare, pharmaceutical and technology influencers and leaders at the 4th Annual WIRED Health event, as they gather to hear compelling stories from the co-inventor of CRISPR; the co-discoverer of the ebola virus; and the chief medical officer of the UK government. …more
![UK flag as shield](https://eurohealth.ie/wp-content/uploads/2015/04/United-Kingdom.png)
Decision approves kidney cancer drug for NHS use
Decision approves kidney cancer drug for NHS use A new draft guidance has recommended everolimus for treating some people with advanced kidney cancer, a drug previously only available through the Cancer Drugs Fund (CDF). The committee looked at new evidence and a price discount submitted by the drugs company, and was able to approve the…
Workshop: Healthy and Secure People, HSP 2017, Porto, Portugal, Apr.28-29, 2017
HSP is an inter-disciplinary research area focused on using scientific models, methodologies and technologies for enhancing human quality of life. In the next seven years 25% of EU citizens will be over the age of 60 and will require to understand health, well being, disease prevention, diagnosing disease,treating and managing disease; active ageing and self-management…
Meeting of OECD Health Ministers, Paris, January 2017
OECD Health Ministerial Meeting, Paris Meeting of OECD Health Ministers 17th January Ministers from over 35 OECD and partner countries met to exchange ideas, ambitions and challenges for The Next Generation of Health Reforms. They addressed issues including: How to tackle ineffective health spending and waste How to make the most of new health technologies…
Public consultation: Building a European data economy
Public consultation on Building a European data economy This public consultation on Building a European data economy will help shaping the future policy agenda on the European data economy. This dialogue with stakeholders follows the adoption of the Communication on Building a European data economy and its accompanying Staff Working Document. Results will feed into…